Showing results (121-130 of 248) with videos related to

Sort By:
Pageof 25
Blood Advances|March 18, 2020
Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serumAndrés J M Ferreri, Marianna Sassone, Elisabetta Miserocchi, et al.
Annals of Hematology|May 15, 2014
Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA studyMathias Witzens-Harig, Robin Foá, Alice Di Rocco, et al.
Hematological Oncology|June 26, 2020
Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinibElisa Rumi, Emanuela Sant'Antonio, Chiara Cavalloni, et al.
Blood|September 9, 2011
Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletionMarco Lucioni, Francesca Novara, Giacomo Fiandrino, et al.
Eclinicalmedicine|April 18, 2024
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatmentLuca Arcaini, Côme Bommier, Juan Pablo Alderuccio, et al.
Haematologica|May 15, 2025
Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamabGianluigi Ardissino, Piera Angelillo, Maria Cristina Mancuso, et al.
Blood|January 8, 2005
Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphomaAlessandro Rambaldi, Emanuela Carlotti, Elena Oldani, et al.
British Journal of Haematology|March 29, 2014
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study GroupAnnarita Conconi, Markus Raderer, Silvia Franceschetti, et al.
Autoimmunity Reviews|September 20, 2016
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statementClodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, et al.
Cancer Medicine|October 1, 2019
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapyEmanuele Cereda, Annalisa Turri, Catherine Klersy, et al.
Pageof 25